Cargando…

Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021

PURPOSE: Vaccine hesitancy's increasing prevalence in the U.S. is hindering COVID-19 vaccination efforts. Understanding why individuals are vaccine hesitant can establish paths to increase vaccinations. As the COVID-19 vaccine landscape develops, reasons for hesitancy have likely shifted over t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gertz, A., Sewalk, K., Brownstein, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884743/
http://dx.doi.org/10.1016/j.ijid.2021.12.140
_version_ 1784660227982884864
author Gertz, A.
Sewalk, K.
Brownstein, J.
author_facet Gertz, A.
Sewalk, K.
Brownstein, J.
author_sort Gertz, A.
collection PubMed
description PURPOSE: Vaccine hesitancy's increasing prevalence in the U.S. is hindering COVID-19 vaccination efforts. Understanding why individuals are vaccine hesitant can establish paths to increase vaccinations. As the COVID-19 vaccine landscape develops, reasons for hesitancy have likely shifted over time. METHODS & MATERIALS: We gathered 757,618 responses between December 6, 2020, and June 13, 2021, from a validated web survey administered by OutbreaksNearMe.org on Momentive.ai. From December 6 to January 11, individuals self-reported on willingness to receive a COVID-19 vaccine, and starting January 12, their COVID-19 vaccination status. Those who indicated being unsure or not planning to get vaccinated were prompted to report their reasoning (non-exclusive.) Proportions of reasoning were calculated as the number indicating that reason over the total question responses. Proportions were compared across time intervals with significant vaccine, pandemic guideline, and political occurrences. RESULTS: 47.1% of the study population are vaccinated, 11.5% are unsure about vaccination, and 11.9% have no plans to get vaccinated. Prior to vaccine approval, 47.2% indicated enough hesitancy to delay vaccination, and 10.8% indicated not wanting any potential COVID-19 vaccine. Overall, the top reported hesitancy reasons were ‘The vaccine being too new/not enough data’ (60.8%) and ‘Concerns about side effects’ (60.0%). ‘Lack of trust in government’ and ‘Lack of trust in scientists’ were less prevalent initially (28.1% and 11.0%), but have been increasing since January 2021, reaching 50.2% and 40.2% in June. ‘COVID-19 being an exaggerated threat’ also follows this trend, starting at 8.7% and reaching 31.6%. ‘Already had COVID-19’ and ‘Never get any vaccine’ are also increasing in prevalence across time, at a slower rate. Different hesitancy reasons have steeper increases throughout the study period corresponding to certain events like new guidelines for vaccinated persons. CONCLUSION: Concerns surrounding side effects and the vaccines’ newness were consistently the top reasons for COVID-19 vaccine hesitancy across the study population. Higher prevalence of lack of trust in government, science, and COVID-19 being exaggerated reasoning have been observed over time. Hesitancy reasoning seems somewhat influenced by significant events, however, those still not getting vaccinated have different reasoning for their hesitancy than was observed earlier in the pandemic.
format Online
Article
Text
id pubmed-8884743
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88847432022-03-01 Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021 Gertz, A. Sewalk, K. Brownstein, J. Int J Infect Dis Topic 09: COVID-19 Vaccines OP09.01 (515) PURPOSE: Vaccine hesitancy's increasing prevalence in the U.S. is hindering COVID-19 vaccination efforts. Understanding why individuals are vaccine hesitant can establish paths to increase vaccinations. As the COVID-19 vaccine landscape develops, reasons for hesitancy have likely shifted over time. METHODS & MATERIALS: We gathered 757,618 responses between December 6, 2020, and June 13, 2021, from a validated web survey administered by OutbreaksNearMe.org on Momentive.ai. From December 6 to January 11, individuals self-reported on willingness to receive a COVID-19 vaccine, and starting January 12, their COVID-19 vaccination status. Those who indicated being unsure or not planning to get vaccinated were prompted to report their reasoning (non-exclusive.) Proportions of reasoning were calculated as the number indicating that reason over the total question responses. Proportions were compared across time intervals with significant vaccine, pandemic guideline, and political occurrences. RESULTS: 47.1% of the study population are vaccinated, 11.5% are unsure about vaccination, and 11.9% have no plans to get vaccinated. Prior to vaccine approval, 47.2% indicated enough hesitancy to delay vaccination, and 10.8% indicated not wanting any potential COVID-19 vaccine. Overall, the top reported hesitancy reasons were ‘The vaccine being too new/not enough data’ (60.8%) and ‘Concerns about side effects’ (60.0%). ‘Lack of trust in government’ and ‘Lack of trust in scientists’ were less prevalent initially (28.1% and 11.0%), but have been increasing since January 2021, reaching 50.2% and 40.2% in June. ‘COVID-19 being an exaggerated threat’ also follows this trend, starting at 8.7% and reaching 31.6%. ‘Already had COVID-19’ and ‘Never get any vaccine’ are also increasing in prevalence across time, at a slower rate. Different hesitancy reasons have steeper increases throughout the study period corresponding to certain events like new guidelines for vaccinated persons. CONCLUSION: Concerns surrounding side effects and the vaccines’ newness were consistently the top reasons for COVID-19 vaccine hesitancy across the study population. Higher prevalence of lack of trust in government, science, and COVID-19 being exaggerated reasoning have been observed over time. Hesitancy reasoning seems somewhat influenced by significant events, however, those still not getting vaccinated have different reasoning for their hesitancy than was observed earlier in the pandemic. Published by Elsevier Ltd. 2022-03 2022-02-28 /pmc/articles/PMC8884743/ http://dx.doi.org/10.1016/j.ijid.2021.12.140 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Topic 09: COVID-19 Vaccines OP09.01 (515)
Gertz, A.
Sewalk, K.
Brownstein, J.
Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title_full Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title_fullStr Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title_full_unstemmed Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title_short Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
title_sort assessing the shift in reasoning for covid-19 vaccine hesitancy in the united states using a six-month cross-sectional analysis from december 2020 to june 2021
topic Topic 09: COVID-19 Vaccines OP09.01 (515)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884743/
http://dx.doi.org/10.1016/j.ijid.2021.12.140
work_keys_str_mv AT gertza assessingtheshiftinreasoningforcovid19vaccinehesitancyintheunitedstatesusingasixmonthcrosssectionalanalysisfromdecember2020tojune2021
AT sewalkk assessingtheshiftinreasoningforcovid19vaccinehesitancyintheunitedstatesusingasixmonthcrosssectionalanalysisfromdecember2020tojune2021
AT brownsteinj assessingtheshiftinreasoningforcovid19vaccinehesitancyintheunitedstatesusingasixmonthcrosssectionalanalysisfromdecember2020tojune2021